|
2024-08-06 |
2024-08-06 |
PS
Planned sale
|
McKew John C.
Chief Scientific Officer
Officer
|
3,407
-21.2%
1.89
USD 6,426
|
3,407
-21.2%
|
1.89
|
USD 6,426
|
|
|
2024-04-03 |
2024-04-03 |
PS
Planned sale
|
McKew John C.
Chief Scientific Officer
Officer
|
2,214
-11.4%
2.78
USD 6,144
|
2,214
-11.4%
|
2.78
|
USD 6,144
|
|
|
2024-02-07 |
2024-02-06 |
PS
Planned sale
|
McKew John C.
Chief Scientific Officer
Officer
|
438
-2.3%
3.03
USD 1,328
|
438
-2.3%
|
3.03
|
USD 1,328
|
|
|
2023-08-03 |
2023-08-02 |
PS
Planned sale
|
McKew John C.
Chief Scientific Officer
Officer
|
3,407
-15.4%
3.21
USD 10,919
|
3,407
-15.4%
|
3.21
|
USD 10,919
|
|
|
2023-04-04 |
2023-04-04 |
PS
Planned sale
|
McKew John C.
Chief Scientific Officer
Officer
|
2,214
-8.7%
3.27
USD 7,240
|
2,214
-8.7%
|
3.27
|
USD 7,240
|
|
|
2023-02-03 |
2023-02-02 |
PS
Planned sale
|
McKew John C.
Chief Scientific Officer
Officer
|
439
-1.6%
3.53
USD 1,550
|
439
-1.6%
|
3.53
|
USD 1,550
|
|
|
2022-11-18 |
2022-11-16 |
B
Purchase
|
McCracken Joseph S
Non-Executive Director
|
4,000
+34.1%
5.03
USD 20,120
|
4,000
+34.1%
|
5.03
|
USD 20,120
|
|
|
2022-09-23 |
2022-09-23 |
B
Purchase
|
Hawkins Richard J
Chief Executive Officer
Executive Director
|
208
+4.9%
8.80
USD 1,830
|
208
+4.9%
|
8.80
|
USD 1,830
|
|
|
2022-09-23 |
2022-09-21 |
B
Purchase
|
Hawkins Richard J
Chief Executive Officer
Executive Director
|
2,214
+108.2%
8.84
USD 19,572
|
2,214
+108.2%
|
8.84
|
USD 19,572
|
|
|
2022-09-21 |
2022-09-20 |
B
Purchase
|
Hawkins Richard J
Chief Executive Officer
Executive Director
|
1,506
+278.4%
8.75
USD 13,178
|
1,506
+278.4%
|
8.75
|
USD 13,178
|
|
|
2022-09-21 |
2022-09-19 |
B
Purchase
|
Hawkins Richard J
Chief Executive Officer
Executive Director
|
541
+inf%
8.65
USD 4,680
|
541
+inf%
|
8.65
|
USD 4,680
|
|
|
2022-08-26 |
2022-08-25 |
B
Purchase
|
Raffin Thomas A.
Non-Executive Director
|
1,150
+13.9%
8.46
USD 9,729
|
1,150
+13.9%
|
8.46
|
USD 9,729
|
|
|
2022-08-26 |
2022-08-25 |
B
Purchase
|
McCracken Joseph S
Non-Executive Director
|
3,170
+37.1%
8.60
USD 27,262
|
3,170
+37.1%
|
8.60
|
USD 27,262
|
|
|
2022-08-03 |
2022-08-02 |
PS
Planned sale
|
McKew John C.
Chief Scientific Officer
Officer
|
3,407
-12.2%
8.11
USD 27,631
|
3,407
-12.2%
|
8.11
|
USD 27,631
|
|
|
2022-06-07 |
2022-06-06 |
PS
Planned sale
|
McKew John C.
Chief Scientific Officer
Officer
|
169
-0.6%
7.62
USD 1,288
|
169
-0.6%
|
7.62
|
USD 1,288
|
|
|
2022-04-05 |
2022-04-05 |
PS
Planned sale
|
McKew John C.
Chief Scientific Officer
Officer
|
2,214
-7.0%
8.32
USD 18,420
|
2,214
-7.0%
|
8.32
|
USD 18,420
|
|
|
2021-01-08 |
2021-01-08 |
S
Sale
|
Flynn James E
Large shareholder
|
101,600
-11.5%
22.24
USD 2,259,797
|
101,600
-11.5%
|
22.24
|
USD 2,259,797
|
|
|
2021-01-08 |
2021-01-08 |
S
Sale
|
Flynn James E
Large shareholder
|
3,912
-0.4%
23.57
USD 92,194
|
3,912
-0.4%
|
23.57
|
USD 92,194
|
|
|
2021-01-08 |
2021-01-08 |
S
Sale
|
Flynn James E
Large shareholder
|
1,000
-0.1%
24.11
USD 24,108
|
1,000
-0.1%
|
24.11
|
USD 24,108
|
|
|
2021-01-08 |
2021-01-07 |
S
Sale
|
Flynn James E
Large shareholder
|
4,378
-0.5%
25.05
USD 109,665
|
4,378
-0.5%
|
25.05
|
USD 109,665
|
|
